Last reviewed · How we verify
NCT05862649: PALOMA
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
NA trial testing NeuraLight in Parkinson Disease in 300 participants. Currently enrolling.
15 November 2025
Quick facts
| Lead sponsor | NeuraLight |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 300 |
| Start date | 21 August 2023 |
| Primary completion | 15 November 2025 |
| Estimated completion | 15 November 2025 |
| Sites | 5 locations across United Kingdom, Switzerland, Portugal, United States, Spain |
Drugs / interventions tested
- NeuraLight
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
NeuraLight
Who can join
Adults 40 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicenter longitudinal study in about 300 patients with Idiopathic Parkinson's disease, who will be evaluated in several clinical centers with a clinical assessment and an oculometric examination during a time period with specific intervals. This study aims to evaluate the correlation between oculometric measures and clinical assessment over time, as well as the potential to detect early change in clinical status using an oculometric assessment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Innovations in Parkinson's Disease: Strategies and Novel Technologies.
Sha R, Dabus MA, Torres-Russotto DR, Bhakuni N, et al · · 2025 · PMID 40761976 · DOI 10.7759/cureus.87309
Verify or expand the search:
- PubMed search for NCT05862649
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NeuraLight
Trials testing the same drug.
- NCT06597071 — Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely · NA · enrolling by invitation
- NCT05795023 — A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients · NA · completed
- NCT05476523 — Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures · recruiting
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other NeuraLight trials
Trials by the same sponsor.
- NCT06597071 — Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely · NA · enrolling by invitation
- NCT05795023 — A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients · NA · completed
- NCT05437003 — A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients · NA · completed
- NCT05476523 — Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures · recruiting
- NCT05407428 — A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05862649 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NeuraLight
- Last refreshed: 20 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05862649.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing